Correction: Prognostic implications of a carefully performed neurological assessment in patients with a first event suggestive of multiple sclerosis

by Miller David H, Edan Gilles, Freedman Mark S, Barkhof Frederik, Polman Chris H, Pohl Christoph, Nielsen Jessica M, Bauer Lars, Sandbrink Rupert, Kappos Ludwig, Uitdehaag Bernard MJ
Published 2011-02-01

MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome

by Nielsen, Jessica M, Pohl, Christoph, Polman, Chris H, Barkhof, Frederik, Freedman, Mark S, Edan, Gilles, Miller, David H, Bauer, Lars, Sandbrink, Rupert, Kappos, Ludwig, Uitdehaag, Bernard MJ
Published 2009

Correction: Prognostic implications of a carefully performed neurological assessment in patients with a first event suggestive of multiple sclerosis

by Nielsen, Jessica M, Pohl, Christoph, Polman, Chris H, Barkhof, Frederik, Freedman, Mark S, Edan, Gilles, Miller, David H, Bauer, Lars, Sandbrink, Rupert, Kappos, Ludwig, Uitdehaag, Bernard MJ
Published 2011

No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT

by Munger, Kassandra L., Fitzgerald, Kathryn C., Freedman, Mark S., Hartung, Hans-Peter, Miller, David H., Montalbán, Xavier, Edan, Gilles, Barkhof, Frederik, Suarez, Gustavo, Radue, Ernst-Wilhelm, Sandbrink, Rupert, Kappos, Ludwig, Pohl, Christoph, Ascherio, Alberto
Published in Neurology (2015)

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial

by Kappos, Ludwig, Edan, Gilles, Freedman, Mark S., Montalbán, Xavier, Hartung, Hans-Peter, Hemmer, Bernhard, Fox, Edward J., Barkhof, Frederik, Schippling, Sven, Schulze, Andrea, Pleimes, Dirk, Pohl, Christoph, Sandbrink, Rupert, Suarez, Gustavo, Wicklein, Eva-Maria
Published in Neurology (2016)

The Developing Regorafenib Eye drops for neovascular Age‐related Macular degeneration (DREAM) study: an open‐label phase II trial

by Joussen, Antonia M., Wolf, Sebastian, Kaiser, Peter K., Boyer, David, Schmelter, Thomas, Sandbrink, Rupert, Zeitz, Oliver, Deeg, Gesa, Richter, Annett, Zimmermann, Torsten, Hoechel, Joachim, Buetehorn, Ulf, Schmitt, Walter, Stemper, Brigitte, Boettger, Michael K.
Published in Br J Clin Pharmacol (2018)

Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis

by Penner, Iris-Katharina, Stemper, Brigitte, Calabrese, Pasquale, Freedman, Mark S, Polman, Chris H, Edan, Gilles, Hartung, Hans-Peter, Miller, David H, Montalbán, Xavier, Barkhof, Frederik, Pleimes, Dirk, Lanius, Vivian, Pohl, Christoph, Kappos, Ludwig, Sandbrink, Rupert
Published 2012

Molecular mechanism underlying the impact of vitamin D on disease activity of MS

by Munger, Kassandra L, Köchert, Karl, Simon, Kelly C, Kappos, Ludwig, Polman, Chris H, Freedman, Mark S, Hartung, Hans P, Miller, David H, Montalbán, Xavier, Edan, Gilles, Barkhof, Frederik, Pleimes, Dirk, Sandbrink, Rupert, Ascherio, Alberto, Pohl, Christoph
Published 2014

Interleukin 17F Level and Interferon Beta Response in Patients With Multiple Sclerosis

by Hartung, Hans-Peter, Steinman, Lawrence, Goodin, Douglas S., Comi, Giancarlo, Cook, Stuart, Filippi, Massimo, O’Connor, Paul, Jeffery, Douglas R., Kappos, Ludwig, Axtell, Robert, Knappertz, Volker, Bogumil, Timon, Schwenke, Susanne, Croze, Ed, Sandbrink, Rupert, Pohl, Christopher
Published in JAMA Neurol (2013)

Predictors of disease activity in 857 patients with MS treated with interferon beta-1b

by Hartung, Hans-Peter, Kappos, Ludwig, Goodin, Douglas S., O’Connor, Paul, Filippi, Massimo, Arnason, Barry, Comi, Giancarlo, Cook, Stuart, Jeffery, Douglas, Petkau, John, White, Richard, Bogumil, Timon, Beckmann, Karola, Stemper, Brigitte, Suarez, Gustavo, Sandbrink, Rupert, Pohl, Christoph
Published in J Neurol (2015)

Subtraction MR Images in a Multiple Sclerosis Multicenter Clinical Trial Setting

by Moraal, Bastiaan, Meier, Dominik S., Poppe, Peter A., Geurts, Jeroen J. G., Vrenken, Hugo, Jonker, William M. A., Knol, Dirk L., van Schijndel, Ronald A., Pouwels, Petra J. W., Pohl, Christoph, Bauer, Lars, Sandbrink, Rupert, Guttmann, Charles R. G., Barkhof, Frederik
Published 2009

Variability in detection and quantification of interferon β-1b–induced neutralizing antibodies

by Hartung, Hans-Peter, Kieseier, Bernd, Goodin, Douglas S, Arnason, Barry GW, Comi, Giancarlo, Cook, Stuart, Filippi, Massimo, Jeffery, Douglas R, Kappos, Ludwig, Bogumil, Timon, Stemper, Brigitte, Sandbrink, Rupert, Nakada, Yukiko, Nakajima, Haruhiko, Schwenke, Susanne, Lehr, Stephan, Heubach, Jürgen, Pohl, Christoph, Reischl, Joachim
Published 2012

Vitamin D as an early predictor of multiple sclerosis activity and progression

by Ascherio, Alberto, Munger, Kassandra L., White, Rick, Köchert, Karl, Simon, Kelly Claire, Polman, Chris H., Freedman, Mark S., Hartung, Hans-Peter, Miller, David H., Montalbán, Xavier, Edan, Gilles, Barkhof, Frederik, Pleimes, Dirk, Radü, Ernst-Wilhelm, Sandbrink, Rupert, Kappos, Ludwig, Pohl, Christoph
Published 2014

Integrating genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility

by De Jager, Philip L., Chibnik, Lori B., Cui, Jing, Reischl, Joachim, Lehr, Stephan, Simon, K. Claire, Aubin, Cristin, Bauer, David, Heubach, Jürgen F., Sandbrink, Rupert, Tyblova, Michaela, Lelkova, Petra, Havrdova, Eva, Pohl, Christoph, Horakova, Dana, Ascherio, Alberto, Hafler, David A., Karlson, Elizabeth W.
Published 2009

MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry

by Bendfeldt, Kerstin, Taschler, Bernd, Gaetano, Laura, Madoerin, Philip, Kuster, Pascal, Mueller-Lenke, Nicole, Amann, Michael, Vrenken, Hugo, Wottschel, Viktor, Barkhof, Frederik, Borgwardt, Stefan, Klöppel, Stefan, Wicklein, Eva-Maria, Kappos, Ludwig, Edan, Gilles, Freedman, Mark S., Montalbán, Xavier, Hartung, Hans-Peter, Pohl, Christoph, Sandbrink, Rupert, Sprenger, Till, Radue, Ernst-Wilhelm, Wuerfel, Jens, Nichols, Thomas E.
Published in Brain Imaging Behav (2018)